Prevalence and importance of comorbidities in patients with heart failure (Q38037383)

27 August 2017

Prevalence and importance of comorbidities in patients with heart failure (English)

1 reference

27 August 2017

0 references

1 reference

Filippos K Triposkiadis

series ordinal

1

1 reference

27 August 2017

John Skoularigis

series ordinal

2

1 reference

27 August 2017

language of work or name

1 reference

1 December 2012

1 reference

Current heart failure reports

27 August 2017

1 reference

27 August 2017

9

1 reference

27 August 2017

4

1 reference

27 August 2017

354-362

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-012-0110-z

27 August 2017

0 references

cites work

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Non-cardiac comorbidities in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The pulmonary manifestations of left heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Pathogenesis of obstructive and central sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Sleep apnea and heart failure: Part II: central sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Treatment of Cheyne-Stokes respiration-central sleep apnea in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The effects of heart failure on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Cardio-Kidney-Damage: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The complexity of the cardio-renal link: taxonomy, syndromes, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Renal function in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Peri-operative renal function and outcome after orthotopic heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The liver in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

21 January 2018

The heart and the liver.

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Pathophysiology of anemia in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Anemia and mortality in heart failure patients a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Mediators of anemia in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Anemia in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Thyroid hormone metabolism in heart failure: iodothyronine deiodinases in focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Thyroid hormone treatment to mend a broken heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Thyroid replacement therapy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Effects of amiodarone therapy on thyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Diabetes in heart failure: prevalence and impact on outcome in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39,505 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Metabolic mechanisms in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Skeletal muscle abnormalities in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Muscle wasting in cardiac cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The "muscle hypothesis" of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Effect of depression on prognosis in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Profile of cognitive impairment in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Cognitive impairment: a key feature of congestive heart failure in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

From risk factors to structural heart disease: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Liver x receptors in atherosclerosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Diabetes and inflammation: fundamental aspects and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Role of cytokines in the pathogenesis of the euthyroid sick syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Neuroendocrine-immune interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Depression: an inflammatory illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Depression and Clinical Outcomes in Heart Failure: An OPTIMIZE-HF Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0110-Z

Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle

21 January 2018

1 reference

12 December 2020

The liver in heart failure

1 reference

12 December 2020

Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure

1 reference

12 December 2020

Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure

1 reference

12 December 2020

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

1 reference

12 December 2020

Lung membrane diffusing capacity, heart failure, and heart transplantation

1 reference

12 December 2020

Oxidative stress, inflammation and cardiovascular disease in chronic renal failure

1 reference

12 December 2020

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure

1 reference

12 December 2020

Natural course and risk factors for impaired renal function during the first year after heart transplantation

1 reference

12 December 2020

Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure

1 reference

12 December 2020

Cognitive impairment in heart failure

1 reference

12 December 2020

10.1007/S11897-012-0110-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference